Muscular dystrophies are a group of genetic disorders characterized by progressive muscle weakness and degeneration. These disorders are caused by mutations in genes that are involved in the structure and function of muscles. Muscular dystrophies can affect people of all ages, but they are most commonly diagnosed in childhood. There are several different types of muscular dystrophies, including Duchenne muscular dystrophy, Becker muscular dystrophy, and myotonic dystrophy, each with its own specific genetic cause and symptoms. Treatment options for muscular dystrophies are limited, and management typically involves physical therapy, mobility aids, and medications to manage symptoms. Researchers are actively working to understand the underlying genetic mechanisms of muscular dystrophies and develop new therapies to slow down or treat the progression of these disorders. Gene therapy, stem cell therapy, and other innovative treatment approaches are being explored in clinical trials to improve the quality of life for individuals with muscular dystrophies.